Guide · Updated 2026
What Insurance Covers GLP-1s
A plain-English breakdown of who covers Wegovy, Zepbound, Ozempic, and Mounjaro in 2026 — and how to find out what your plan will actually pay for.
How commercial insurance decides
Even if BCBS, Aetna, Cigna, or United "covers" Wegovy on their national formulary, your specific plan may exclude weight-loss drugs. That's because employers self-fund most large plans and choose whether to include the anti-obesity medication rider. Ask HR whether your plan covers AOMs — that single question answers most coverage questions.
Commercial coverage snapshot (2026)
- Blue Cross Blue Shield. Wegovy and Zepbound on most formularies; PA required; employer opt-in for weight loss indication.
- Aetna. Covers Wegovy and Zepbound with PA, BMI thresholds, and often a documented weight-loss attempt.
- Cigna. Broad Wegovy coverage; Zepbound added to most formularies in 2025. Requires PA and BMI documentation.
- UnitedHealthcare. Coverage varies significantly by plan; many exclude weight-loss meds entirely.
- Kaiser Permanente. Regional variation; typically requires enrollment in a Kaiser weight-management program first.
Medicare and Medicaid
Medicare Part D is legally barred from covering drugs "used for the treatment of anorexia, weight loss, or weight gain." That means Wegovy and Zepbound aren't covered for weight loss. Two exceptions matter: Ozempic and Mounjaro are covered for type 2 diabetes, and Wegovy gained coverage in 2024 for cardiovascular risk reduction in patients with established heart disease and overweight/obesity.
Medicaid coverage is state-by-state. States that cover Wegovy or Zepbound for weight loss (2026) include California, Pennsylvania, Michigan, Massachusetts, Virginia, and about 10 others — all with strict PA criteria.
How to check your own coverage in 5 minutes
- Get your insurance card and the drug name (e.g., Wegovy).
- Call the member services number on the back of the card.
- Ask: "Is [drug name] on my formulary, what tier, and is prior authorization required?"
- Ask specifically: "Does my plan cover anti-obesity medications?"
- If yes, ask what BMI and documentation the PA requires.
If your plan doesn't cover it
- Wegovy savings card: Commercially insured (with coverage) pay as little as $0/mo; without coverage, $650/mo off the list price.
- Zepbound savings card: $25/mo with coverage, up to $469/mo without via LillyDirect self-pay vials.
- Compounded semaglutide/tirzepatide: $150–$400/mo through telehealth providers.
FAQ
Which insurance covers GLP-1s for weight loss?
Most large commercial plans (Blue Cross Blue Shield, Aetna, Cigna, UnitedHealthcare) cover Wegovy or Zepbound if your employer opted into the anti-obesity medication rider. Diabetes GLP-1s (Ozempic, Mounjaro) are covered when you have a type 2 diabetes diagnosis.
Does Medicare cover GLP-1s for weight loss?
Not for weight loss alone. Medicare Part D covers Ozempic and Mounjaro for type 2 diabetes, and Wegovy is covered when prescribed for cardiovascular risk reduction in patients with established heart disease.
Does Medicaid cover Wegovy or Zepbound?
It varies by state. As of 2026, roughly 15 state Medicaid programs cover Wegovy or Zepbound for weight loss with prior authorization; most require a BMI ≥ 30 or ≥ 27 with comorbidities.
How do I check my GLP-1 coverage?
Call the member services number on the back of your insurance card and ask if Wegovy, Zepbound, Ozempic, or Mounjaro is on your formulary, what tier, and whether prior authorization is required.
What if my insurance doesn't cover it?
Options include manufacturer savings cards (Wegovy, Zepbound), LillyDirect self-pay vials, or compounded semaglutide/tirzepatide through a telehealth provider.
See which providers match your situation
Take a 90-second questionnaire and we'll rank your top 3 telehealth providers by medication, budget, and state availability.
Find My Top 3 MatchesEducational content, not medical advice. Talk to a licensed clinician before starting or changing any medication.